Transparency Assessment of COVID-19 Models
View ORCID ProfileMohammad S. Jalali, Catherine DiGennaro, Devi Sridhar
doi: https://doi.org/10.1101/2020.07.18.20156851
Mohammad S. Jalali
1MGH Institute for Technology Assessment, Harvard Medical School, Boston, MA, USA
2MIT Sloan School of Management, Cambridge, MA, USA
Catherine DiGennaro
1MGH Institute for Technology Assessment, Harvard Medical School, Boston, MA, USA
Devi Sridhar
3Medical School, The University of Edinburgh, Edinburgh, UK
4Centre for Population Health Sciences, The University of Edinburgh, Edinburgh, UK

Data Availability
All data used in the assessment are reported in the supplementary document.
Posted July 21, 2020.
Transparency Assessment of COVID-19 Models
Mohammad S. Jalali, Catherine DiGennaro, Devi Sridhar
medRxiv 2020.07.18.20156851; doi: https://doi.org/10.1101/2020.07.18.20156851
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)